• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. EFFECTS OF ORAL ANTI-VIRAL AGENTS ON LONG-TERM OUTCOMES OF TREATMENT NA(I)VE PATIENTS WITH HBVRELATE

EFFECTS OF ORAL ANTI-VIRAL AGENTS ON LONG-TERM OUTCOMES OF TREATMENT NA(I)VE PATIENTS WITH HBVRELATE

来源 :2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 | 被引量 : 0次 | 上传用户：ghosty
【摘 要】
：
Background:Data regarding the long term outcome of HBV-related decompensated cirrhosis is rare,especially following oral nucleos(t)ide analogues use in such patients.
【作 者】
：
Gangde Zhao Pei Hu Hai Li Ting Gao Shuting Li Huijuan Zhou Weiliang Tang Hui Wang Rongtao Lai Weijing Wang Qing Xie 
【机 构】
：
Department of Infectious Diseases,Ruijin Hospital,School of Medicine,Shanghai Jiao Tong University,S
【出 处】
：
2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议
【发表日期】
：
2014年4期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:Data regarding the long term outcome of HBV-related decompensated cirrhosis is rare,especially following oral nucleos(t)ide analogues use in such patients.
其他文献
PROGNOSTIC VALUE OF SERUM WNT5A FOR ACUTE ON CHRONIC HEPATITIS B LIVER FAILURE
Objectives:To find a biomarker to predict the prognosis of acute on chronic hepatitis B liver failure(ACHBLF).Methods:This study included 63 patients with ACHBLF,60 patients with chronic hepatitis B(C
会议
A model to predict the initiation of antiviral treatment in patients with HBeAg positive chronic hep
Background:Liver biopsy is recommended before therapy for patients with HBeAg-positive chronic hepatitis B(CHB) when alanine aminotransferase(ALT) Less than or equal to2upper limit of normal(ULN) and
会议
The implementation of clinical pathway in HBV related liver failure decreased mortality:A prospectiv
Background:In order to manage the healthcare quality and reduce mortality of hepatitis B virus(HBV) related liver failure,a prospective multicenter study was performed in 10 large liver center in Chin
会议
OVEREXPRESSION OF SERUM SST2 ASSOCIATE WITH POOR PROGNOSIS IN ACUTE-ON-CHRONIC HEPATITIS B LIVER FAI
Background:Interleukin-33(IL-33) and soluble ST2(sST2) have been demonstrated to be associated with liver injury.
会议
Recovery of the Frequency of Activating and Inhibitory Receptor-Expressing Natural Killer Cells and
Background:Protective immune response plays an important role in eliminating HBV infection.A weak immune response to HBV can lead to chronic liver disease.
会议
Response to Entecavir(ETV)in patients with Chronic Hepatitis B(CHB)and primary non-response to Adefo
Background:Elevated HBV DNA levels are associated with increased risk for liver cancer and cirrhosis.Rapid and complete viral suppression correlates with lower rate of resistance development.Effective
会议
Impaired function of CD4+T follicular helper(Tfh)cells associated with hepatocellular carcinoma prog
Background:CD4+T follicular helper(Tfh) cells,a new subset of immune cells,have been demonstrated to be involved in the development and prognosis of tumors.
会议
Assembly of Lipid-Polymer Hybrid Nanoparticles for Encapsulating a Non-nucleosidic Novel HBV Inhibit
Background:The advent of nanotechnology has provided a new and powerful tool in medical fields.Of all the application of nanotechnology,nanoparticle-delivery system attracted many attentions.As a deli
会议
Study of influence factors on HBV relapse after NAs withdrawl in the HBeAg positive CHB patients who
Background:Oobjective:To explore the influence factors on HBV relapse after Nucleos(t)ide analogues(NAs)withdrawal in the Hepatitis B e antigen positive chronic hepatitis B(CHB)patients who met NAs ce
会议
INVESTIGATION OF ETIOLOGY AND CLINICAL CHARACTERISTICS OF 573 PATIENTS SUFFERED FROM PRIMARY HEPATIC
Objective:To investigate etiology,risk factors and clinical characteristics of primary hepatic carcinoma(PHC)in Hebei province to better strategies for disease prevention,diagnosis and treatment.
会议